全文获取类型
收费全文 | 1768篇 |
免费 | 105篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 79篇 |
妇产科学 | 34篇 |
基础医学 | 189篇 |
口腔科学 | 26篇 |
临床医学 | 251篇 |
内科学 | 345篇 |
皮肤病学 | 45篇 |
神经病学 | 83篇 |
特种医学 | 299篇 |
外科学 | 149篇 |
综合类 | 44篇 |
一般理论 | 1篇 |
预防医学 | 150篇 |
眼科学 | 33篇 |
药学 | 135篇 |
中国医学 | 3篇 |
肿瘤学 | 74篇 |
出版年
2023年 | 12篇 |
2022年 | 15篇 |
2021年 | 25篇 |
2020年 | 17篇 |
2019年 | 32篇 |
2018年 | 36篇 |
2017年 | 17篇 |
2016年 | 25篇 |
2015年 | 34篇 |
2014年 | 41篇 |
2013年 | 55篇 |
2012年 | 69篇 |
2011年 | 53篇 |
2010年 | 53篇 |
2009年 | 65篇 |
2008年 | 62篇 |
2007年 | 106篇 |
2006年 | 51篇 |
2005年 | 53篇 |
2004年 | 37篇 |
2003年 | 37篇 |
2002年 | 31篇 |
2001年 | 43篇 |
2000年 | 45篇 |
1999年 | 35篇 |
1998年 | 84篇 |
1997年 | 76篇 |
1996年 | 67篇 |
1995年 | 56篇 |
1994年 | 50篇 |
1993年 | 52篇 |
1992年 | 34篇 |
1991年 | 30篇 |
1990年 | 36篇 |
1989年 | 49篇 |
1988年 | 38篇 |
1987年 | 34篇 |
1986年 | 28篇 |
1985年 | 26篇 |
1984年 | 27篇 |
1983年 | 19篇 |
1982年 | 23篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 7篇 |
1978年 | 19篇 |
1977年 | 29篇 |
1976年 | 18篇 |
1975年 | 18篇 |
1974年 | 11篇 |
排序方式: 共有1950条查询结果,搜索用时 39 毫秒
1.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
2.
S Lori Brown Roselie A Bright Diane E Dwyer Betsy Foxman 《Journal of human lactation》2005,21(2):169-174
Breast pumps are medical devices used to express milk and maintain the milk supply. The purpose of this study was to characterize adverse events reported to the United States Food and Drug Administration (FDA) on breast pumps. Thirty-seven adverse event reports on breast pumps were identified from the Manufacturer and User Facility Device Experience database between 1992 and 2003. Four additional reports were found in the Device Experience Network database from 1992 to 1996. The most commonly reported adverse events for electric breast pumps were pain, soreness, or discomfort; the need for medical intervention; and breast tissue damage. Most frequently reported problems for manual breast pumps were breast tissue damage and infection. Contamination of breast milk during pumping was also reported. Breast pump adverse events are likely underreported to the FDA. Reporting adverse events is important for improving the design and manufacture of breast pumps and subsequently decreasing adverse events. 相似文献
3.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
4.
5.
J E Bright A C Woodman T C Marrs S G Wood 《Xenobiotica; the fate of foreign compounds in biological systems》1987,17(1):79-83
A methaemoglobin former, 4-aminopropiophenone (p-aminopropiophenone, PAPP), which is active only after metabolic activation in vivo, exhibits a sex difference in male Beagle dogs and bitches. Bitches produced more methaemoglobin for a given dose of PAPP than male dogs. The probable reason for this difference was a lower rate of N-hydroxylation in male dogs. 相似文献
6.
1 The standard drug for the treatment of arsenic poisoning is BAL (dimercaprol). BAL possesses marked side-effects and a low safety ratio, drawbacks which new BAL analogues, DMPS and DMSA, do not possess. 2 The efficacy of three chelating agents, BAL, DMPS and DMSA, has been evaluated as a treatment for systemic organic arsenic poisoning, induced by intravenous dichloro(2-chlorovinyl)arsine (lewisite) administration to rabbits. Equimolar dosing schedules were used based upon realistic doses for the most toxic agent, BAL. 3 It was concluded that all three dimercapto chelating agents provided significant protection against the lethal systemic effects of lewisite, and, under the test conditions reported here, there was no significant difference between them in therapeutic efficacy. 4 The cause of mortality following intravenous lewisite in treated and untreated rabbits was pulmonary damage. 5 It is considered that DMPS and DMSA are worthy of further study as replacements for BAL in the treatment of systemic poisoning by lewisite. 相似文献
7.
8.
SUMMARY A young patient presenting with splenomegaly and hypersplenism was inadvertently found to have selective IgA deficiency. There were no symptoms of immunodeficiency and the patient responded well to splenectomy, with return of blood counts to normal without adverse effects. No other cause for the hypersplenism was found. We postulate selective IgA deficiency as a cause of splenomegaly and hypersplenism. 相似文献
9.
10.
Jane Maienschein James L. W. West Betty Bright 《Pediatric nephrology (Berlin, Germany)》2004,19(12):1437-1438